BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8066191)

  • 1. Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance.
    Haustermans K; van der Kogel AJ; Vanacker B; van der Schueren E
    Radiother Oncol; 1994 May; 31(2):123-8. PubMed ID: 8066191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of nicotinamide and carbogen on the radiation tolerance of the spinal cord of the rat].
    Raabe A
    Strahlenther Onkol; 1994 Nov; 170(11):674-5. PubMed ID: 7974185
    [No Abstract]   [Full Text] [Related]  

  • 3. Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice.
    Sun LQ; Coucke PA; Mirimanoff RO; Buchegger F
    Radiat Res; 2001 Jan; 155(1 Pt 1):26-31. PubMed ID: 11121212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.
    Rojas A; Hirst VK; Calvert AS; Johns H
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):357-65. PubMed ID: 8567336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
    Ono K; Masunaga S; Akuta K; Akaboshi M; Abe M
    Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A; Vojnovic B; Johns H; Joiner MC; Martindale C; Fowler JF; Denekamp J
    Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ; Horsman MR; Siemann DW
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.
    Siemann DW; Horsman MR; Chaplin DJ
    Radiother Oncol; 1994 May; 31(2):117-22. PubMed ID: 8066190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A; Menke D; Dorie MJ; Brown JM
    Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen.
    Sibtain A; Hill S; Goodchild K; Shah N; Saunders M; Hoskin PJ
    Radiother Oncol; 2002 Jan; 62(1):69-76. PubMed ID: 11830314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide and carbogen: relationship between pO2 and radiosensitivity in three tumour lines.
    Martin LM; Thomas CD; Guichard M
    Int J Radiat Biol; 1994 Mar; 65(3):379-86. PubMed ID: 7908317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single- and multifraction irradiation.
    Fenton BM; Lord EM; Paoni SF
    Radiat Res; 2000 Jan; 153(1):75-83. PubMed ID: 10630980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinamide and carbogen: major effect on the radiosensitivity of EMT6 and HRT18 tumours.
    Simon JM; Lartigau E; Guichard M
    Radiother Oncol; 1993 Sep; 28(3):203-7. PubMed ID: 8255997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in Fischer 344 rats.
    Braun RD; Lanzen JL; Turnage JA; Rosner G; Dewhirst MW
    Radiat Res; 2001 May; 155(5):724-33. PubMed ID: 11302770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermic enhancement of tumor radiosensitization strategies.
    Griffin RJ; Ogawa A; Williams BW; Song CW
    Immunol Invest; 2005; 34(3):343-59. PubMed ID: 16136785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
    Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined.
    Honess DJ; Bleehen NM
    Br J Cancer; 1995 Jun; 71(6):1175-80. PubMed ID: 7779707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide.
    Brizel DM; Hage WD; Dodge RK; Munley MT; Piantadosi CA; Dewhirst MW
    Radiat Res; 1997 Jun; 147(6):715-20. PubMed ID: 9189170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON).
    Zackrisson B; Franzén L; Henriksson R; Littbrand B; Stratford M; Dennis M; Rojas AM; Denekamp J
    Acta Oncol; 1994; 33(4):377-81. PubMed ID: 8018369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.